The landscape of diabetes management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatid and Retatrutide represent key advancements; The Tirzepatide already https://retatrutide40mg766057.blogsvirals.com/profile